bexarotene has been researched along with gw 501516 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ferrara, SJ; Scanlan, TS | 1 |
Alitalo, K; Anisimov, A; Eckel, RH; Ehnholm, C; Jauhiainen, M; Koistinen, HA; Olkkonen, VM; Robciuc, MR; Skrobuk, P | 1 |
2 other study(ies) available for bexarotene and gw 501516
Article | Year |
---|---|
A CNS-Targeting Prodrug Strategy for Nuclear Receptor Modulators.
Topics: Amides; Amidohydrolases; Animals; Blood-Brain Barrier; Brain; Diffusion; Mice; Mice, Inbred C57BL; Molecular Targeted Therapy; Prodrugs; Receptors, Cytoplasmic and Nuclear; Tissue Distribution | 2020 |
Angiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubes.
Topics: Angiopoietin-Like Protein 4; Angiopoietins; Animals; Bexarotene; Blotting, Western; Cell Line; Cells, Cultured; Fatty Acids; Gene Expression; Humans; Lipoprotein Lipase; Male; Mice; Mice, Inbred BALB C; Middle Aged; Muscle Fibers, Skeletal; Oxidation-Reduction; Palmitates; PPAR delta; Rats; Retinoid X Receptors; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Tetrahydronaphthalenes; Thiazoles | 2012 |